Skip to main content
. Author manuscript; available in PMC: 2015 Nov 1.
Published in final edited form as: J Diabetes. 2014 Sep 18;6(6):614–616. doi: 10.1111/1753-0407.12178

Figure 1.

Figure 1

Fasting glucose (mg/dL) values and Ad36 status of rhesus monkeys during year 1 – 2 of a HFS diet study where half of the animals were receiving daily resveratrol treatment. A two-way ANCOVA to evaluate changes in fasting glucose revealed a significant association for Ad36 status (p = 0.021) with Ad36 positive animals having greater change in fasting glucose over the one year time period (A) (removed data points are included in the graph ○). A significant experimental group by Ad36 status interaction was also found (p < 0.001) suggesting that fasting glucose levels are affected by Ad36 status based on resveratrol treatment group (B) (Mean ±SEM).